Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience.

Autor: Chitanava T; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia., Matvienko I; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia., Shuvaev V; Clinical and Diagnostic Department of Hematology and Chemotherapy with a Day Patient Facility, Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia., Voloshin S; Clinical Department of Hematology, Chemotherapy and Bone Marrow Transplantation with Intensive Care Unit, Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia., Martynkevich I; Research Center of Cellular and Molecular Pathology, Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia., Vlasova Y; Bone Marrow Transplantation Department for Adults, Raisa Gorbacheva Memorial Research Institute of Children's Oncology, Hematology and Transplantation First I. Pavlov State Medical University of St. Petersburg, Saint Petersburg, Russia., Efremova E; Clinical Department of Hematology, Chemotherapy and Bone Marrow Transplantation with Intensive Care Unit, Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia., Mileeva E; Clinical and Diagnostic Department of Hematology and Chemotherapy with a Day Patient Facility, Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia., Pirkhalo A; Clinical and Diagnostic Department of Hematology and Chemotherapy with a Day Patient Facility, Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia., Makarova T; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia., Vlasik R; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia., Karyagina E; Department of Oncohematology, Chemotherapy and Bone Marrow Transplantation №11, City Clinical Hospital №15, Saint Petersburg, Russia., Il Ina N; Trans-Regional Hematology Department, City Clinical Hospital №15, Saint Petersburg, Russia., Medvedeva N; Center for Outpatient Oncological Care, City Clinical Hospital №31, Saint Petersburg, Russia., Dorofeeva N; Center for Outpatient Oncological Care, City Clinical Hospital №31, Saint Petersburg, Russia., Shneider T; Center for Outpatient Oncological Care, City Clinical Hospital №31, Saint Petersburg, Russia., Siordiya N; Department of Chemotherapy and Bone Marrow Transplantation №2, Almazov National Medical Research Centre, Saint Petersburg, Russia., Kulemina O; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia.; Department of Chemotherapy and Bone Marrow Transplantation №2, Almazov National Medical Research Centre, Saint Petersburg, Russia., Sbityakova E; Department of Specialized Medical Care for Oncology Patients, Almazov National Medical Research Centre, Saint Petersburg, Russia., Lazorko N; Department of Specialized Medical Care for Oncology Patients, Almazov National Medical Research Centre, Saint Petersburg, Russia., Alexeeva J; Department of Chemotherapy and Bone Marrow Transplantation №2, Almazov National Medical Research Centre, Saint Petersburg, Russia., Motorin D; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia.; Department of Chemotherapy and Bone Marrow Transplantation №2, Almazov National Medical Research Centre, Saint Petersburg, Russia., Morozova E; Department of Oncology Hematology and Transplantation for Adolescent and Adults, Raisa Gorbacheva Memorial Research Institute of Children's Oncology, Hematology and Transplantation First I. Pavlov State Medical University of St. Petersburg, Saint Petersburg, Russia., Lomaia E; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russia.; Department of Faculty Therapy with Clinic, Almazov National Medical Research Centre, Saint Petersburg, Russia.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Mar 16; Vol. 13, pp. 1138683. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).

Materials of the II conference ⇜current issues of diagnosis and treatment of ph-negative and ph-positive myeloproliferative neoplasms⇝ (March 15-16, 2019; national research center for hematology, moscow),Материалы II конференции «Актуальные вопросы диагностики и лечения Ph-негативных и Ph-позитивных миелопролиферативных заболеваний» (15-16 марта 2019 г., ФГБУ «НМИЦ гематологии» Минздрава России, Москва)

Autor: Melikyan, A. L., Turkina, A. G., Subortseva, I. N., Chelysheva, E. Yu, Kovrigina, A. M., Shuvaev, V. A., Baikov, V. V., Vinogradova, O. Yu, Kulikov, S. M., Petrova, A. N., Bykova, A. V., Poshivai, A. -P A., Vlasova, Yu Yu, Chukavina, M. M., Serdyuk, O. D., Naumova, K. V., Siordiya, N. T., Lazorko, N. S., Grozov, R. V., Mullo, E. I., Maksimova, A. S., Senderova, O. M., Kanya, O. V., Mikhail Fominykh, Shikhbabaeva, D. I., Belyakova, E. A., Martynkevich, I. S., Polushkina, L. B., Zenina, M. N., Efremova, E. V., Rugal, V. I., Papayan, L. P., Korsakova, N. E., Matvienko, O. Yu, Syrtseva, E. B., Gappoev, S. V., Barabanshchikova, M. V., Ivanova, M. O., Kaplanov, K. D., Rogova, E. S., Trizna, K. B., Zhevnyak, A. S., Ochirova, O. E., Shakhaeva, A. A., Lyamkina, A. S., Mikhno, I. P., Chernykh, Yu B., Chudanova, T. V., Kontievskii, I. N., Glonina, N. N., Burundukova, M. V.

Publikováno v: Scopus-Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::de46160897b6d625cb41624a207278e9
http://www.scopus.com/inward/record.url?eid=2-s2.0-85097309408&partnerID=MN8TOARS

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco.

Autor: Benchikh S; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco. sara.benchikh1-etu@etu.univh2c.ma.; Laboratory of Physiopathology and Molecular Genetics, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco. sara.benchikh1-etu@etu.univh2c.ma., Charlène SSG; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco.; Laboratory of Biology and Health, Faculty of Sciences Ben M'sik, Casablanca, Morocco., Bousfiha A; Laboratory of Physiopathology and Molecular Genetics, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco., Razoki L; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco., Aboulfaraj J; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco., Zarouf L; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco., Hamouchi AE; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco., Malki A; Laboratory of Physiopathology and Molecular Genetics, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco., Nassereddine S; Laboratory of Cytogenetics, Pasteur Institute of Morocco, Casablanca, Morocco.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 2765-2774. Date of Electronic Publication: 2024 Apr 24.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.